You are here

Home » Content

AĞIZ İÇİNDE GÖRÜLEN OTOİMMUN VEZİKÜLOBÜLLÖZ HASTALIKLAR

COMMONLY OCCURING ORAL AUTOIMMUNE BLISTERING DISEASES

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
A selection of autoimmune blistering diseases, including pemphigus vulgaris, paraneoplastic pemphigus, bullous pemphigoid and cicatricial pemphigoid are reviewed. Pemphigus vulgaris usually starts in the oral mucosa followed by blistering of the skin, which is often painful. Paraneoplastic pemphigus is associated with neoplasms, most commonly of lymphoid tissue, but also Waldenstrom's macroglobulinemia, sarcomas, thymomas and CasllemaiVs disease. Bullous pemphigoid is characterized by large, tense bullae, but may begin as an urticarial eruption. Cicatricial (scarring) pemphigoid presents with severe, erosive lesions of the mucous membranes with skin involvement in one third of patients focused around the head and upper trunk.
Bookmark/Search this post with
Abstract (Original Language): 
Otoimmun vezikülobtillöz hastalıklardan, beiirgİn ağız lezyotıları ile birlikte seyreden pemfigus vulgaris, paraneoplastik pemfigus, bültöz pemfıgoid, skalrisiyel pemfigoid ile ilgili literatür derlemesi yapılmıştır. Pemfigus vulgaris genellikle oral mukozada başlar, daha sonra deri lezyonları .oluşur. Pemfigus vulgaristeki bu tezyonlar ağrılıdır. Paraneoplastik pemfigus neoplazmlar ile birlikte ortaya çıkar, bu neoplazmlar genellikle lenfoid dokunun neoplazmlarıdır. Fakat bunun yanında Waldenströmün makroglobulinemiası, sarkomlar, timomalar ve Castlemannm hastalığı gibi diğer hastalıklar ile de ortaya çıkabilir. Büllöz pemfigoid geniş, gergin bililer ile karakterizedir fakat ürtiker tarzında döküntüler İle başlayabilir. Skatrisiyel pemfigoid müköz membran ile deride yaygın, şiddetli, eroziv Iezyonlar ile karakterizedir. Bu lezyonlar hastaların üçte birinde gövdenin üst kısımlarında ve baş çevresinde odaklanmışlardır.
FULL TEXT (PDF): 
PDF icon arastirmax-agiz-icinde-gorulen-otoimmun-vezikulobulloz-hastaliklar.pdf
  • 3-4
45
55
  • Turkish

REFERENCES

References: 

1. Mutasim D F. Autoimmune bullous dermatoses in the elderly diagnosis and management. Drags Aging. 2003: 20: 663-681.
2. Grove GL, Duncan S, Kligman AM. Effect of aging on the blistering of human skin with ammonium hydroxide. Br J Dermatol, 1982: 107: 383-400.
3. Montagna W, Carlisle K. Structural changes in aging human skin. J Invest Dermatol, 1979: 73: 47-53.
4. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol, 1997: 84:517-534.
5. Bickle KM, Roark TR. Autoimmune bullous dermatoses: a review. American Family Physician, 2002:9: 1861-1870.
6. Zegarelli DJ, Zegarelli EV. Intraoral pemphigus. Oral Surg Oral Med Oral Pathol, 1977: 44: 384-393.
7. Siegel MA, Balciunas BA, Kelly M, Serio FG. Diagnosis and management of commonly occuring oral vesiculoerosive disorders. Cutis, 1991:47: 39-43.
8. Lever WP. Pemphigus and pemphigoid: a review of the advantages made since 1964. J Am Acad Dermatol, 1979: 1:2-31.
9. Gilmore UK. Early detection of pemphigus vulgaris. Oral Surg, 1978: 46: 641-644.
10. Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus patients. Dermatology, 2001: 203: 201-207.
11. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol, 1997: 12: 77-97.
12. Orlowski WA, Bressman E, Doyle JL, Chascns AI. Chronic pemphigus vulgaris of the gingiva. J Periodontol 1983, 54: 685-689.
13. Director W. Pemphigus vulgaris: a cl ini copatho logical study. Arch Dermatol Syphilol, 1952: 65: 155-169.
14. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris-incidence in Jews of different ethnic groups according to age,sex, and initial lesion. Oral Surg Oral Med Oral Pathol, 1974: 38: 382-387.
15. Hasimoto K, Lever VF. An electron microscobic study of pemphigus vulgaris of the mounth and skin with special reference to the intercellular cement. J Invest Dermatol, 1967: 48:540-552.
16. Lamey PJ, Ress TD, Binnie WH, Wright JM, Rankin KV, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol, 1992: 74: 54-57.
17. Krain LS, Landau JW, Newcomer VD. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol, 1972: 106: 657-661.
Ağız İçinde Görülen Otoimmun Vezikülobüllöz Hastalıklar
18. Bystryn JC, Steİnman NM. The adjuvant therapy of pemphigus. Arch Dermatol, 1996: 132: 203-212.
19. Anhalt GJ, Kim S, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med, 1990: 323: 1729¬1735.
20. Lee IJ, Kim SC, Kim HS, Bang D, et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castlcman's tumor. J Am Acad Dermatol, 1999: 40: 294-297.
21. Foster ME, Nally FF. Benign mucous membrane pemphigoid (cicatricial mucosal pemphigoid): a reconsideration. Oral Surg Oral Med Oral Pathol, 1977: 44: 697-705.
22. Gallagher C, Shklar G. Oral involvement in mucous membrane pemphigoid. Clin Dermatol, 1987: 5: 18-27.
23. Miller BA, Gomitsky M. Benign mucous membrane pemphigoid: a case report. J Can Dent Assoc, 1991: 57: 799-800.
24. Dahi MGG, Cook LJ. Lesions induced by trauma İn pemphigoid. Br J Dermatol, 1979: 101: 469-473.
25. Venning VA, Frith PA, Bron AJ, et al. Mucosal involvement in bullous and cicatricial pemphigoid: a clinical and immunopatholo-gical study. Br J Dermatol, 1988: 118: 7-15.
26. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: direct and indirect İmmunoflorescent studies. Oral Surg Oral Med Oral Pathol, 1981:51:48-54.
27. Mutasim DF, Diaz LA. The relevance of immunohistochemical techniques İn the differentiation of subepidermal bullous diseases. Am J Dermatopathol, 1991: 13: 77¬83.
28. Kirtschİg G, Murrell D, Wojnarowska F, et al. Interventions for mucous membrane
pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita. Arch Dermatol, 2002: 138: 380-384.
29. Lamely PJ, Rees TD, Binnie WH, Rankin KV. Mucous membrane pemphigoid: treatment experience at two instutions. Oral Surg Oral Med Oral Pathol, 1992: 74: 50-53.
30. Ahmed AR, Colon JE. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens İn patients with severe oral pemphigoid. Arch Dermatol, 2001: 137: 1181-1189.
31. Provost TT, Maize JC, Ahmed AR, et al. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol, 1979: 115: 156-160.
32. Ahmed AR, Maize JC, Provost TT. Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol, 1977: 113: 1043-1046.
33. Bingham EA, Burrow D, Sanford JC. Prolonged pruritus and bullous pemphigoid. Clin Exp Dermatol 1984, 9: 564-570.
34. Person JR, Rogers III RS. Bullous and cicatricial pemphigoid: clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc, 1977: 52: 54-66.
35. Flotte TJ. Pathology of pemphigoid. Clin Dermatol, 1987: 5: 71-80.
36. Siege! J, Eaglstein WH. High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol, 1984: 120: 1157¬1165.
37. Wojnarowska F, Kirtschİg G, Highet AS, et al. Guidelines for the management of bullous pemphigoid. Br J Dermatol, 2002: 147: 214-21.
38. Goldberg NS, Robinson JK, Roenigk Jr HH, et al. Plasmapheresis therapy for bullous pemphigoid. Arch Dermatol, 1985: 121: 1484¬1485.

Thank you for copying data from http://www.arastirmax.com